Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates

In-Vitro Testing of Pregnancy Malaria Vaccine Candidates

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Background: \- Malaria is a disease that affects many people in African countries. It is caused by germs that are spread by mosquito bites. It can be fatal if not diagnosed and treated right away. Children younger than 5 and pregnant women are most at risk to get malaria. Researchers want to create a vaccine that will prevent malaria infection during pregnancy. Objectives: \- To create a vaccine that will prevent malaria infection during pregnancy. To assess possible vaccines using in-vitro tests with parasites taken from pregnant women. Eligibility: \- Pregnant women ages 15-25 Design: * The study site is an area in Mali, West Africa. * Participants: * Will have blood drawn. * Will give consent for the blood sample to be used for future research. * May have a physical exam. * Participants who have malaria or anemia will get treatment.

Who May Be Eligible (Plain English)

* Who May Qualify: A study participant must satisfy the following criteria to be enrolled in this study: - Pregnant women aged 15-25 years - Able to provide consent for self - Malaria positive by rapid diagnostic test (RDT) Who Should NOT Join This Trial: - Severe anemia defined as HGB\<7 gr/dL, that may be worsened by 10 mL phlebotomy - Conditions that in the judgment of the investigator could increase the risk to the volunteer - Prior enrollment to the study during the same pregnancy Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
* INCLUSION CRITERIA: A study participant must satisfy the following criteria to be enrolled in this study: * Pregnant women aged 15-25 years * Able to provide consent for self * Malaria positive by rapid diagnostic test (RDT) EXCLUSION CRITERIA: * Severe anemia defined as HGB\<7 gr/dL, that may be worsened by 10 mL phlebotomy * Conditions that in the judgment of the investigator could increase the risk to the volunteer * Prior enrollment to the study during the same pregnancy

Locations (1)

Ouelessebougou Clinical Research Center
Bamako, Mali